Summary
- The "value approach" narrative misses the structural setup: an ~11% discount to NAV, active share buybacks, and a 3.66% dividend yield.
- The manager controls 25–30% of the trust and has stakes exceeding 20% in six individual holdings - the highest level of skin in the game in the UK investment trust industry.
- The trust is buying its own shares at approximately 1,598.50p per share, compounding the discount-arbitrage effect.
- FY2025 portfolio profit fell to £96,235,000 from £151,591,000 - a real headwind that the discount is partially reflecting.
- I rate ASL a Buy for investors who can tolerate illiquidity in UK small caps and want a dividend-compounding wrapper with institutional-grade alignment.
I've been very surprised that the research spotlight on Aberforth Smaller Companies Trust keeps landing on its "value approach" as if that is the news. The investment style is the background condition, not the thesis. What matters is the structural mechanics: a persistent 11% discount to NAV, an active share buyback program, and a 3.66% dividend yield. These three variables create an investment case that has nothing to do with whether the manager picks value stocks.
Let me decompose what is actually happening.
1. The discount is the entry point, not the investment philosophy.
The trust trades at approximately an 11% discount to its net asset value - meaning investors are buying £1 of underlying portfolio assets for roughly 89p. For those who don't trade investment trusts regularly, this is the fundamental difference: the shares trade separately from the portfolio they own, and that gap can open or close independently of the underlying stock picks. The discount has persisted for years, but as of June 2026, it sits at roughly 11%. That is not the widest it has been historically, but it is wide enough to matter when combined with the next two factors.
2. The buyback program compounds the structural advantage.
Aberforth has been actively repurchasing its own shares throughout 2026. In June alone, the trust bought 40,000 shares at 1,598.5p per share and 16,500 shares around 1,600p. On May 28, it repurchased 15,000 shares at 1,617.7p. This is not a one-off gesture. It is a systematic program that buys at the discount, which mechanically increases the NAV per remaining share. Each repurchase is a direct transfer of value from sellers to continuing shareholders. The buyback yield - the annual repurchase rate as a percentage of market capitalization - effectively adds to the 3.66% dividend yield, creating a total capital return that exceeds what the headline dividend alone suggests.
3. The manager's alignment is the highest in the sector.
Aberforth's management team controls between 25% and 30% of the trust's shares. More specifically, at the end of December 2025, the firm held stakes exceeding 20% in six individual portfolio holdings and stakes above a lower threshold in 28 holdings. This is not co-investment window dressing. When the manager owns a quarter of the trust at the same discount as retail investors, their economic interest is structurally aligned. They are buying at the same price, at the same time, in the same vehicle. Few UK investment trusts have this level of manager skin in the game.
The counterargument: FY2025 profit fell, and the discount is not irrational.
The portfolio delivered £96.2M of profit for the year ended December 2025, down sharply from £151.6M in 2024. The NAV total return was 7.9% for the year - solid, but the share price total return lagged because the discount did not close. This is the reason the discount exists. UK small caps have suffered from years of underperformance against large caps and global equities, and the sentiment penalty has been persistent.
However, the 11% discount is not a reflection of portfolio deterioration. It is a reflection of market structure - the same structural bias against UK small-cap investment trusts that has existed for years. The portfolio returned 7.9% on an NAV basis. If the discount had remained stable, the share price would have delivered the same return. The gap between NAV and share price is a market sentiment issue, not a portfolio quality issue.
The holdings are not the point - the wrapper is.
The top holdings - CMC Markets, Zigup, Vesuvius, Rathbones, Ashmore Group - are diversified UK small-cap companies across financials, technology, and materials. The 0.80% ongoing charge is reasonable for an actively managed trust, though it is not the cheapest in the category. What matters is not which stocks are inside but the structural wrapper: discount entry, buyback compounding, dividend yield, and manager alignment. These mechanics work regardless of which specific small caps Aberforth holds, provided the portfolio generates positive NAV growth over time - and 7.9% in 2025 demonstrates it does.
That being the case, I rate Aberforth Smaller Companies Trust (ASL) a Buy.
The investment case is not the "value approach" that the research reports are spotlighting. It is the structural combination of buying a diversified UK small-cap portfolio at an ~11% discount, with the manager on the same side of the trade owning 25–30%, with share buybacks actively compounding the advantage, and a 3.66% dividend underneath. For investors who can tolerate the illiquidity inherent in UK small caps and the persistence of the discount, ASL offers a wrapper that structurally favors the buyer. The value philosophy is the least interesting thing about it.